Skip to main content
Fig. 1 | Clinical Epigenetics

Fig. 1

From: The prognostic value and immune correlation of IL18 expression and promoter methylation in renal cell carcinoma

Fig. 1

IL18 is highly expressed and associated with poor prognosis in RCC patients. A. Relative mRNA expression of IL18 between tumor and adjacent normal tissues using the data from TCGA cohort; B Relative expression of IL18 between tumor and adjacent normal tissues using the data from CPTAC cohort; CF The expression of IL18 expression in different stages and pathological grades of patients from TCGA cohort; G, H Kaplan–Meier survival analysis of IL18 expression for overall survival and disease-free survival of patients from TCGA RCC cohort, respectively

Back to article page